[1] |
Niesporek S, Denkert C, Weichert W, et al.
Expression of lysophosphatidic acid acyltransferase beta(LPAAT-beta)in ovarian carcinoma: correlation with tumour grading and prognosis[J]. Br J CancerBr J Cancer, 2005, 92(9): 1729-1736.
doi: 10.1038/sj.bjc.6602528
|
[2] |
Jonkers J, Moolenaar WH.
Mammary tumorigenesis through LPA receptor signaling[J]. Cancer CellCancer Cell, 2009, 15(6): 457-459.
doi: 10.1016/j.ccr.2009.05.003
|
[3] |
Yu S, Murph MM, Lu Y, et al.
Lysophosphatidic acid receptorsdetermine tumorigenicity and aggressiveness of ovarian cancer cells[J]. J Natl Cancer InstJ Natl Cancer Inst, 2008, 100(22): 1630-1642.
doi: 10.1093/jnci/djn378
|
[4] |
Ren J, Xiao YJ, Singh LS, et al.
Lysophosphatitic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhsion, migration, and invasion of ovarian cancer cells[J]. Cancer ResCancer Res, 2006, 66(6): 3006-3014.
doi: 10.1158/0008-5472.CAN-05-1292
|
[5] |
Shida D, Kitayama J, Yamaguchi H, et al.
Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells[J]. World J GastroenterolWorld J Gastroenterol, 2005, 11(36): 5638-5643.
doi: 10.3748/wjg.v11.i36.5638
|
[6] |
徐文生, 黄艳丽, 蒙玉刚, 等.
卵巢恶性上皮性肿瘤血浆溶血磷脂酸与CA125诊断价值的对比观察[J]. 中华肿瘤防治杂志中华肿瘤防治杂志, 2008, 15(11): 840-842.
doi: 10.3969/j.issn.1673-5269.2008.11.012
|
[7] |
Sutphen R, Xu Y, Wilbanks GD, et al.
Lysophospholipids are potential biomarkers of ovarion cancer[J]. Cancer Epidemiol Biomarkers PrevCancer Epidemiol Biomarkers Prev, 2004, 13(7): 1185-1191.
|
[8] |
肖焕擎, 杨洁, 孙政, 等.
溶血磷脂酸在胃恶性上皮性肿瘤患者中表达及意义[J]. 临床和实验医学杂志临床和实验医学杂志, 2008, 7(1): 75-76.
doi: 10.3969/j.issn.1671-4695.2008.01.048
|